SCHEMBL5470367

SCHEMBL5470367

CCOC(=O)c1c(NC(=O)c2cc[nH]n2)sc2c1CCCC2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 8/20 0.68
▸ HPGD P15428 7/20 0.68
▸ ALDH1A1 P00352 7/20 0.68
▸ KDM4E B2RXH2 6/20 0.68
▸ NPSR1 Q6W5P4 5/20 0.68
▸ ALOX15 P16050 3/20 0.68
▸ LMNA P02545 1/20 0.68
▸ MAPT P10636 7/20 0.66
▸ TP53 P04637 1/20 0.66
▸ RXFP1 Q9HBX9 1/20 0.65
▸ L3MBTL1 Q9Y468 2/20 0.64
▸ MAPK1 P28482 3/20 0.64
▸ TDP1 Q9NUW8 2/20 0.64
▸ GAA P10253 1/20 0.63
▸ TSHR P16473 2/20 0.62
▸ USP2 O75604 1/20 0.62
▸ PTGER2 P43116 1/20 0.62
▸ CASP1 P29466 1/20 0.61
▸ CASP7 P55210 1/20 0.61
▸ CNR2 P34972 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3914054 0.82 MAPT (0.82) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL3923508 0.81 MAPT (0.77) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL3916162 0.81 MAPT (0.80) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL7892222 0.81 MAPT (0.84) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL8289604 0.80 MAPT (0.78) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL13561104 0.80 MAPT (1.00) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL3917114 0.80 MAPT (0.82) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL21247199 0.79 MAPT (1.00) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL16562058 0.79 MAPT (0.80) HSD17B10HPGDALDH1A1KDM4ENPSR1
SCHEMBL8290510 0.78 MAPT (0.77) HSD17B10HPGDALDH1A1KDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225318-A1 Pyrazole Compounds Useful In The Treatment Of Inflammation BIOLIPOX AB (SE) 2007-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225318-A1 Pyrazole Compounds Useful In The Treatment Of Inflammation ALOX15, ALOX15B, ALOX12 HSD17B10 762/4885HPGD 66/4885ALDH1A1 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback